False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials

Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research & potential conflicts between the principles of scientific methodology & those of patients' best interests. The emotional &...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Hastings Center report 1987-04, Vol.17 (2), p.16-19
Hauptverfasser: Vanderpool, Harold Y., Weiss, Gary B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19
container_issue 2
container_start_page 16
container_title The Hastings Center report
container_volume 17
creator Vanderpool, Harold Y.
Weiss, Gary B.
description Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research & potential conflicts between the principles of scientific methodology & those of patients' best interests. The emotional & social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA
doi_str_mv 10.2307/3562037
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_60970633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3562037</jstor_id><sourcerecordid>3562037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1583-17143026dad6a69b0a3763e3874337235fffd354c835798dd4677554861fc02f3</originalsourceid><addsrcrecordid>eNp10E1LAzEQBuAgCtYq_oWAoqfVJJOv9Sa1tcWCHip4W9LdbElJszXZHvz3prQnwbnMYR5ehheha0oeGBD1CEIyAuoEDagQrKBcfp2iASElFASAn6OLlNYkD9cwQG8T45PFL6Y32IQGz03q8bTb2vSExyF23ruwwrNgvVu5pbf4w_TOhj5hF_AoH11tPF5El2Mu0Vm7T7s67iH6nIwXo2kxf3-djZ7nRU2FhoIqyoEw2ZhGGlkuiQElwYJWHEAxEG3bNiB4rUGoUjcNl0oJwbWkbU1YC0N0d8jdxu57Z1NfbVyqrfcm2G6XKklKRSRAhjd_4LrbxZB_qygrGSVaS5nV_UHVsUsp2rbaRrcx8aeipNpXWh0rzfL2INep7-K_7BdYT2_H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1292108866</pqid></control><display><type>article</type><title>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</title><source>Jstor Complete Legacy</source><source>Sociological Abstracts</source><source>Periodicals Index Online</source><creator>Vanderpool, Harold Y. ; Weiss, Gary B.</creator><creatorcontrib>Vanderpool, Harold Y. ; Weiss, Gary B.</creatorcontrib><description>Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research &amp; potential conflicts between the principles of scientific methodology &amp; those of patients' best interests. The emotional &amp; social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA</description><identifier>ISSN: 0093-0334</identifier><identifier>EISSN: 1552-146X</identifier><identifier>DOI: 10.2307/3562037</identifier><identifier>CODEN: HSCRAS</identifier><language>eng</language><publisher>Hastings-on-Hudson, N.Y: The Hastings Center</publisher><subject>Cancer ; Clinical trials ; Ethical justification ; Experimentation ; False Data &amp; the Therapeutic Misconception: Two Urgent Problems in Research Ethics ; Hope ; Life expectancy ; Medical Research ; Moral judgment ; Morality ; Patients ; Physicians ; Professional Ethics ; Research ethics ; Researcher Subject Relations ; Respect</subject><ispartof>The Hastings Center report, 1987-04, Vol.17 (2), p.16-19</ispartof><rights>Copyright 1987 The Hastings Center</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1583-17143026dad6a69b0a3763e3874337235fffd354c835798dd4677554861fc02f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3562037$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3562037$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27846,27901,27902,33752,57992,58225</link.rule.ids></links><search><creatorcontrib>Vanderpool, Harold Y.</creatorcontrib><creatorcontrib>Weiss, Gary B.</creatorcontrib><title>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</title><title>The Hastings Center report</title><description>Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research &amp; potential conflicts between the principles of scientific methodology &amp; those of patients' best interests. The emotional &amp; social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA</description><subject>Cancer</subject><subject>Clinical trials</subject><subject>Ethical justification</subject><subject>Experimentation</subject><subject>False Data &amp; the Therapeutic Misconception: Two Urgent Problems in Research Ethics</subject><subject>Hope</subject><subject>Life expectancy</subject><subject>Medical Research</subject><subject>Moral judgment</subject><subject>Morality</subject><subject>Patients</subject><subject>Physicians</subject><subject>Professional Ethics</subject><subject>Research ethics</subject><subject>Researcher Subject Relations</subject><subject>Respect</subject><issn>0093-0334</issn><issn>1552-146X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>K30</sourceid><sourceid>BHHNA</sourceid><recordid>eNp10E1LAzEQBuAgCtYq_oWAoqfVJJOv9Sa1tcWCHip4W9LdbElJszXZHvz3prQnwbnMYR5ehheha0oeGBD1CEIyAuoEDagQrKBcfp2iASElFASAn6OLlNYkD9cwQG8T45PFL6Y32IQGz03q8bTb2vSExyF23ruwwrNgvVu5pbf4w_TOhj5hF_AoH11tPF5El2Mu0Vm7T7s67iH6nIwXo2kxf3-djZ7nRU2FhoIqyoEw2ZhGGlkuiQElwYJWHEAxEG3bNiB4rUGoUjcNl0oJwbWkbU1YC0N0d8jdxu57Z1NfbVyqrfcm2G6XKklKRSRAhjd_4LrbxZB_qygrGSVaS5nV_UHVsUsp2rbaRrcx8aeipNpXWh0rzfL2INep7-K_7BdYT2_H</recordid><startdate>19870401</startdate><enddate>19870401</enddate><creator>Vanderpool, Harold Y.</creator><creator>Weiss, Gary B.</creator><general>The Hastings Center</general><general>Institute of Society, Ethics and the Life Sciences</general><scope>AAYXX</scope><scope>CITATION</scope><scope>JQCIK</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7U4</scope><scope>BHHNA</scope><scope>DWI</scope><scope>WZK</scope></search><sort><creationdate>19870401</creationdate><title>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</title><author>Vanderpool, Harold Y. ; Weiss, Gary B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1583-17143026dad6a69b0a3763e3874337235fffd354c835798dd4677554861fc02f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Cancer</topic><topic>Clinical trials</topic><topic>Ethical justification</topic><topic>Experimentation</topic><topic>False Data &amp; the Therapeutic Misconception: Two Urgent Problems in Research Ethics</topic><topic>Hope</topic><topic>Life expectancy</topic><topic>Medical Research</topic><topic>Moral judgment</topic><topic>Morality</topic><topic>Patients</topic><topic>Physicians</topic><topic>Professional Ethics</topic><topic>Research ethics</topic><topic>Researcher Subject Relations</topic><topic>Respect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vanderpool, Harold Y.</creatorcontrib><creatorcontrib>Weiss, Gary B.</creatorcontrib><collection>CrossRef</collection><collection>Periodicals Index Online Segment 33</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access &amp; Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access &amp; Build (Plan A) - APAC</collection><collection>Primary Sources Access &amp; Build (Plan A) - Canada</collection><collection>Primary Sources Access &amp; Build (Plan A) - West</collection><collection>Primary Sources Access &amp; Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - Midwest</collection><collection>Primary Sources Access &amp; Build (Plan A) - North Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>Sociological Abstracts (pre-2017)</collection><collection>Sociological Abstracts</collection><collection>Sociological Abstracts</collection><collection>Sociological Abstracts (Ovid)</collection><jtitle>The Hastings Center report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vanderpool, Harold Y.</au><au>Weiss, Gary B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</atitle><jtitle>The Hastings Center report</jtitle><date>1987-04-01</date><risdate>1987</risdate><volume>17</volume><issue>2</issue><spage>16</spage><epage>19</epage><pages>16-19</pages><issn>0093-0334</issn><eissn>1552-146X</eissn><coden>HSCRAS</coden><abstract>Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research &amp; potential conflicts between the principles of scientific methodology &amp; those of patients' best interests. The emotional &amp; social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA</abstract><cop>Hastings-on-Hudson, N.Y</cop><pub>The Hastings Center</pub><doi>10.2307/3562037</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0093-0334
ispartof The Hastings Center report, 1987-04, Vol.17 (2), p.16-19
issn 0093-0334
1552-146X
language eng
recordid cdi_proquest_miscellaneous_60970633
source Jstor Complete Legacy; Sociological Abstracts; Periodicals Index Online
subjects Cancer
Clinical trials
Ethical justification
Experimentation
False Data & the Therapeutic Misconception: Two Urgent Problems in Research Ethics
Hope
Life expectancy
Medical Research
Moral judgment
Morality
Patients
Physicians
Professional Ethics
Research ethics
Researcher Subject Relations
Respect
title False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T18%3A47%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=False%20Data%20and%20Last%20Hopes:%20Enrolling%20Ineligible%20Patients%20in%20Clinical%20Trials&rft.jtitle=The%20Hastings%20Center%20report&rft.au=Vanderpool,%20Harold%20Y.&rft.date=1987-04-01&rft.volume=17&rft.issue=2&rft.spage=16&rft.epage=19&rft.pages=16-19&rft.issn=0093-0334&rft.eissn=1552-146X&rft.coden=HSCRAS&rft_id=info:doi/10.2307/3562037&rft_dat=%3Cjstor_proqu%3E3562037%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1292108866&rft_id=info:pmid/&rft_jstor_id=3562037&rfr_iscdi=true